Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: INTELLIGENT FIBER OPTIC SYSTEMS CORPORATION
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2019-03-05 to 2022-12-03
Current total value of award: $749836
Description: EO14042 IFOS IS DEVELOPING A MULTIFUNCTIONAL WHOLE-BLOOD ANALYSIS LAB-ON-A-CHIP PLATFORM FOR ASSESSMENT OF KIDNEY HEALTH. THE IFOS INNOVATIONS ARE FOUND IN EACH SUBSYSTEM, INCLUDING PHOTONIC INTEGRATED CIRCUITS (PICS), MICROELECTRONICS, AND BIOCHEMICAL MICROFLUIDICS. THE UNIQUE DIFFERENTIATED DESIGN IS EXPECTED TO RESULT IN A LOW SWAP-C, HIGHLY MANUFACTURABLE, AND HIGHLY RELIABLE ON-DEMAND MEASUREMENT PLATFORM FOR DIVERSE MEDICAL APPLICATIONS BOTH ON EARTH AND DURING SPACE MISSIONS. IN PHASE 1, THE IFOS MULTIDISCIPLINARY TEAM   INCLUDING STANFORD S MEDICAL AND ENGINEERING DEPARTMENTS   DEMONSTRATED THE FEASIBILITY OF IFOS  INNOVATIVE PIC-BASED PLATFORM. THE TEAM NOT ONLY ACCOMPLISHED ALL TECHNICAL OBJECTIVES BUT WENT BEYOND WITH AN IN-DEPTH EXPLORATION OF THE COMMERCIAL POTENTIAL AND END USE OF THE IFOS INNOVATIONS THROUGH DIRECT INTERACTION WITH OVER 100 POTENTIAL CUSTOMERS AND USERS. THIS IS EXPECTED TO SIGNIFICANTLY ENHANCE AND ACCELERATE THE GO-TO-MARKET PROCESS. PHASE 2 BUILDS ON THE SOLID TECHNICAL AND COMMERCIAL FOUNDATIONS TO COMPLETE THE R&D AND TRANSFORM THE FEASIBILITY RESULTS INTO A PORTABLE, MULTIFUNCTIONAL, RELIABLE AND COMMERCIALLY VIABLE PRODUCT (BIO*SENSE ) READY FOR PRODUCTION. IFOS  TEAM OF MEDICAL EXPERTS AND ADVISORS WILL ACCELERATE THE REGULATORY AND GO-TO-MARKET PROCESSES. STRONG EVIDENCE OF COMMERCIAL VIABILITY IS INDICATED BY THE ENDORSEMENT OF MEDICAL COMMUNITY EXPERTS AND ATTAINMENT OF INVESTMENT COMMITMENT FOR PHASES 2/3.